Insufficient scRNA-seq data for expression of IRF2BP1 at single-cell level.
Insufficient scRNA-seq data for expression of IRF2BP1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 2488.11 | 180 / 180 | 100% | 81.18 | 430 / 430 |
thymus | 100% | 1604.08 | 653 / 653 | 100% | 59.30 | 605 / 605 |
esophagus | 100% | 1671.92 | 1443 / 1445 | 100% | 52.91 | 183 / 183 |
brain | 100% | 2036.65 | 2638 / 2642 | 100% | 52.37 | 705 / 705 |
uterus | 100% | 2387.15 | 170 / 170 | 100% | 49.37 | 458 / 459 |
liver | 100% | 1297.88 | 226 / 226 | 100% | 44.72 | 405 / 406 |
adrenal gland | 100% | 1804.02 | 258 / 258 | 100% | 56.20 | 229 / 230 |
prostate | 100% | 1931.51 | 245 / 245 | 99% | 72.17 | 499 / 502 |
intestine | 100% | 1851.96 | 966 / 966 | 99% | 49.28 | 523 / 527 |
skin | 100% | 1620.69 | 1809 / 1809 | 99% | 53.01 | 468 / 472 |
pancreas | 100% | 1025.63 | 327 / 328 | 99% | 40.92 | 177 / 178 |
kidney | 100% | 1409.07 | 89 / 89 | 99% | 31.30 | 892 / 901 |
breast | 100% | 1579.10 | 459 / 459 | 99% | 48.00 | 1105 / 1118 |
stomach | 100% | 1546.37 | 358 / 359 | 99% | 53.47 | 282 / 286 |
bladder | 100% | 1869.62 | 21 / 21 | 98% | 44.03 | 493 / 504 |
lung | 99% | 1056.25 | 570 / 578 | 98% | 38.94 | 1129 / 1155 |
adipose | 100% | 1277.78 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 62.85 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 41.39 | 29 / 29 |
spleen | 100% | 1608.24 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 44.44 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 49.36 | 1 / 1 |
blood vessel | 100% | 1655.20 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1482.84 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 100% | 1129.20 | 858 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 89% | 695.43 | 829 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | IRF2BP1 |
Protein name | Interferon regulatory factor 2-binding protein 1 (IRF-2-binding protein 1) (IRF-2BP1) (Probable E3 ubiquitin-protein ligase IRF2BP1) (EC 2.3.2.27) (Probable RING-type E3 ubiquitin transferase IRF2BP1) |
Synonyms | |
Description | FUNCTION: Acts as a transcriptional corepressor in a IRF2-dependent manner; this repression is not mediated by histone deacetylase activities. May act as an E3 ligase towards JDP2, enhancing its polyubiquitination. Represses ATF2-dependent transcriptional activation. . |
Accessions | ENST00000302165.5 Q8IU81 |